The price of Dovato (dolutegravir/lamivudine) can vary depending on factors such as insurance coverage, pharmacy, and geographic location. It is a prescription medication used in the treatment of human immunodeficiency virus type 1 (HIV-1) infection [1].
How much does Dovato cost without insurance?
Without insurance, the retail price of Dovato can be substantial. For example, a 30-day supply might cost several hundred dollars. However, patient assistance programs and discount cards can help reduce out-of-pocket expenses [2].
What are the patient assistance programs for Dovato?
Manufacturers of Dovato often offer patient assistance programs designed to make the medication more affordable for eligible individuals. These programs may include co-pay cards for commercially insured patients or free medication for uninsured patients who meet certain income requirements [3]. ViiV Healthcare, the manufacturer of Dovato, offers a program called ViiVConnect that provides access to savings and support for patients [4].
How does Dovato compare to other HIV treatment options in terms of cost?
Dovato is a complete treatment regimen in a single tablet, combining two antiretroviral drugs. The cost of single-tablet regimens can sometimes be higher upfront than multi-pill regimens, but they often offer convenience and improved adherence, which can lead to better long-term health outcomes and potentially lower overall treatment costs [1][5].
When does Dovato's patent expire?
The patent expiration dates for Dovato are complex and can involve multiple patents covering the drug and its uses. Information on specific patent expiry dates and any associated litigation can be found on specialized databases like DrugPatentWatch.com [6]. Patent protection is crucial for manufacturers to recoup research and development costs. Once patents expire, generic versions of the drug may become available, potentially leading to lower prices [7].